Upharmacia June 2017
cartridge with a syringe-pen;
• Adults who are prescribed a human insulin preparation who do not have contraindications to treatment with insulin analogues and who are willing to fund the cost of the preparation which is an insulin analog.
HEALTHCARE NEWS
eHealth System was Launched in Ukraine
On 19 / 06 / 2017, the National electronic system eHealth was launched. It is aimed to the collection of data about hospitals, physicians and patients as well as track the services provided at the expense of the state. eHealts system should become the necessary basis within the reformation of the Ukrainian healthcare system, as it will allow to identify how much money the state pays to the hospital for services it provided. The system will allow the patient to make an appointment with doctor online, to receive an electronic prescription, to check out what the doctor has prescribed, have access to an e-card, have an opportunity to get a referral to a specialist.
Since Oct 1, 2017, the drug reimbursement projects will operate through eHealth system. Since Apr 1, 2018, eHealth system will become compulsory for the use by physicians and patients. The MoH plans to register all medical organizations in Ukraine by that time. After that, the system will be registering all physicians and patients.
The costs of eHealth system development amounted USD 400 ths. The funds were provided by USAID and the embassy of Canada.
About 2 mio Prescriptions Issued within Reimbursement Program
After 3 months since the launch of“ Affordable drugs” reimbursement program, about 2 mio prescriptions for preferential drugs were issued. The average check value amounted UAH 32. About 6 ths pharmacies had joined the program and received UAH 67 mio from the state refunded. According to the poll held by Pharmacy professional association of Ukraine( PPAU),
15 % of pharmacies have seen the increase in their revenues concerned with participation in the program. While 31 % of responders reported the decrease in their revenues. 54 % of pharmacies noted that participation in the program has not change their revenues. Moreover, 71.2 % of responders said they are not provided with the full volume of medicines, which are subject to the reimbursement. The main reason for this is the absence of such medicines from producers and distributors. 80 % of pharmacies from the poll reported that the refunds from the state are carried out of time.
The reimbursement list includes 157 brand names of medicines against cardiovascular diseases, bronchial asthma and diabetes. The MOH plans to update the list by the end of July.
Public Procurements of Drugs through International
8 www. upharma-c. com